Sign Up to like & get
recommendations!
1
Published in 2022 at "Expert Opinion on Therapeutic Targets"
DOI: 10.1080/14728222.2022.2029412
Abstract: ABSTRACT Introduction Cholangiocarcinoma (CCA) is a heterogeneous group of aggressive biliary malignancies. While surgery and liver transplantation are the only potentially curative modalities for early-stage disease, limited options are available for most patients with incurable-stage…
read more here.
Keywords:
novel emerging;
targets cholangiocarcinoma;
cholangiocarcinoma progression;
progression therapeutic ... See more keywords